Intelligent Bio Solutions Inc. Advances on FDA 510(k) Pathway with Biocompatibility Study Success
July 18, 2024 08:30 ET
|
Intelligent Bio Solutions, Inc.
NEW YORK, July 18, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing...
Intelligent Bio Solutions Strengthens UK Market Position with Addition of Key Manufacturing Accounts
July 09, 2024 08:30 ET
|
Intelligent Bio Solutions, Inc.
NEW YORK, July 09, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing...
Intelligent Bio Solutions Completes In-Clinic Portion of Pharmacokinetic (PK) Study Part of 510(k) Pathway for Approval & Commences Review of Results
June 28, 2024 08:30 ET
|
Intelligent Bio Solutions, Inc.
NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing...
Intelligent Bio Solutions Expands Presence in the UK Retail Sector with Major Account Acquisitions
June 27, 2024 08:30 ET
|
Intelligent Bio Solutions, Inc.
NEW YORK, June 27, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing...
Psychemedics Unveils Inaugural Insights Report: Revealing Drug Trends Through Hair Testing
June 21, 2024 10:00 ET
|
Psychemedics Corporation
Psychemedics Corporation releases its inaugural 2024 Insights Report, offering a comprehensive analysis of workplace drug trends from 2023.
Intelligent Bio Solutions Begins Subject Dosing and Sampling for FDA 510(k) Pharmacokinetic (PK) Study for its Intelligent Fingerprinting Drug Screening Technology
June 18, 2024 08:30 ET
|
Intelligent Bio Solutions, Inc.
NEW YORK, June 18, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing...
ClearStar Announces Appointment of Pam Dunsky as Chief Operating Officer
February 28, 2024 10:47 ET
|
ClearStar
ClearStar appoints Pam Dunsky as Chief Operating Officer (COO) to oversee Client Service and Operations.
Expanding Mice Model Market Propels Life Sciences Research, Forecasts a Surge to $2.54 Billion by 2030
January 24, 2024 11:07 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Mice Model Market by Service (Breeding, Cryopreservation, Genetic Testing), Type (Conditioned/Surgically Modified Mice, Genetically Engineered...
United States Humanized Mice Model Research Report 2023: Markets, Competition, Forecast and Opportunities, 2018-2028
November 24, 2023 10:18 ET
|
Research and Markets
Dublin, Nov. 24, 2023 (GLOBE NEWSWIRE) -- The "United States Humanized Mice Model Market, Competition, Forecast and Opportunities, 2018-2028" report has been added to ResearchAndMarkets.com's...
ClearStar announces appointment of Mike Pritts as Chief Executive Officer
November 03, 2023 16:50 ET
|
ClearStar
Alpharetta, Georgia, Nov. 03, 2023 (GLOBE NEWSWIRE) -- ClearStar, Inc., a leading provider of modern, integrated, background, drug, and health screening solutions, is pleased to announce the...